Draeger, Inc. Announces FDA Clearance for Evita V800 Software 3.10 - Advancing Ventilation Technology
Draeger, Inc. Announces FDA Clearance for Evita V800 Software 3.10 - Advancing Ventilation Technology |
| [22-June-2026] |
TELFORD, Pa. , June 22, 2026 /PRNewswire/ -- Draeger, Inc., US headquarters of Dräger, an international leader in the field of medical technology and a worldwide leader in mechanical ventilation, announced today that it has received 510(k) clearance from the FDA to market its latest advancements for the Evita V800 ventilator.
With the clearance of the 3.10 software release, the V800 provides additional features to help enhance mechanical ventilation of patients suffering from pulmonary disease such as ARDS.
"Dräger continues to be on the forefront of technology, the addition of these new features for the Evita V800 is another example of Dräger's commitment to research and development for respiratory care. Dräger is proud to again serve our customers with the latest technology," said Lothar Thielen, President & CEO for Draeger, Inc. For more information, visit the website at www.draeger.com or contact your local Dräger sales representative at 1-800-4DRAGER. You can find more information and pictures in our press center: Dräger is an international leader in the fields of medical and safety technology. Our products protect, support, and save lives. Founded in 1889, Dräger generated revenues of around € 3,5 billion in 2025. The Dräger Group is currently present in over 190 countries and has more than 16,000 employees worldwide. Please visit http://www.draeger.com for more information. Contact
SOURCE Draeger | ||
Company Codes: OTC-PINK:DGWPF,OTC-BB:DGWPF |
View original content to download multimedia:
